A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy.
作者信息
Lapchak Paul A
机构信息
Departments of Neurology and Neurosurgery, Cedars-Sinai Medical Center, Advanced Health Sciences Pavilion Suite 8305, 127 S. San Vicente Blvd., Los Angeles, CA, 90048, USA,
出版信息
Transl Stroke Res. 2015 Apr;6(2):99-103. doi: 10.1007/s12975-015-0386-x. Epub 2015 Feb 1.
Abstract
摘要
相似文献
1
A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy.一种经济高效的兔栓塞性中风生物测定法：对急性缺血性中风治疗发展的见解。
Transl Stroke Res. 2015 Apr;6(2):99-103. doi: 10.1007/s12975-015-0386-x. Epub 2015 Feb 1.
2
Tenecteplase for acute ischemic stroke.替奈普酶用于急性缺血性卒中
Int J Stroke. 2011 Dec;6(6):509-10. doi: 10.1111/j.1747-4949.2011.00695.x.
3
Breaking up is hard to do: tenecteplase in acute stroke.分手不易：急性卒中中的替奈普酶
Lancet Neurol. 2015 Apr;14(4):343-5. doi: 10.1016/S1474-4422(15)70036-0. Epub 2015 Feb 26.
4
Analysis of the Efficacy and Safety of Recombinant Tissue Plasminogen Activator for Chinese Patients over 80 Years of Age with Acute Ischemic Stroke: A Pilot Study.重组组织型纤溶酶原激活剂治疗80岁以上中国急性缺血性脑卒中患者的疗效和安全性分析：一项前瞻性研究
Neurosci Bull. 2016 Apr;32(2):202-3. doi: 10.1007/s12264-016-0020-2. Epub 2016 Mar 9.
5
Can we extend thrombolysis indications for acute ischaemic stroke? The IST-3 study.我们能否扩大急性缺血性卒中的溶栓适应症？IST-3研究。
Intern Emerg Med. 2013 Apr;8(3):261-2. doi: 10.1007/s11739-012-0899-1. Epub 2013 Mar 1.
6
[The treatment of acute ischemic stroke].[急性缺血性卒中的治疗]
Orv Hetil. 2004 Nov 7;145(45):2297-301.
7
Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma.组织型纤溶酶原激活剂在一名合并脑膜瘤的急性缺血性脑卒中患者中的应用。
Clin Neurol Neurosurg. 2009 Jul;111(6):562-3. doi: 10.1016/j.clineuro.2009.01.004. Epub 2009 Feb 6.
8
Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.组织型纤溶酶原激活剂、缺血性中风及潜在法律问题综述
Arch Neurol. 2008 Nov;65(11):1429-33. doi: 10.1001/archneur.65.11.1429.
9
Thrombolytic therapy for acute ischemic stroke: risks vs benefits.急性缺血性卒中的溶栓治疗：风险与获益
J Fam Pract. 2003 Oct;52(10):757, 761.
10
Thrombolysis of acute ischemic stroke in a HIV-positive patient: Report and review of literature.一名HIV阳性患者急性缺血性卒中的溶栓治疗：病例报告及文献综述
Neurol India. 2019 Mar-Apr;67(2):580-582. doi: 10.4103/0028-3886.258007.
引用本文的文献
1
Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.细胞保护药物 - 组织纤溶酶原激活物蛋白酶相互作用测定：两种新型细胞保护色酮的筛选
Transl Stroke Res. 2017 Apr 12. doi: 10.1007/s12975-017-0533-7.
2
Data Standardization and Quality Management.数据标准化和质量管理。
Transl Stroke Res. 2018 Feb;9(1):4-8. doi: 10.1007/s12975-017-0531-9. Epub 2017 Mar 10.
3
Translational Stroke Research Opportunities and a Strategy to Develop Effective Cytoprotection.转化性中风研究机遇与开发有效细胞保护作用的策略
Transl Stroke Res. 2017 Aug;8(4):318-321. doi: 10.1007/s12975-017-0529-3. Epub 2017 Mar 8.
4
Stroke Cytoprotection: Can Repeating History with New Expectations Really Be the Path to Success in Stroke Research?中风细胞保护：带着新期望重演历史真的能成为中风研究成功之路吗？
Transl Stroke Res. 2017 Apr;8(2):104-106. doi: 10.1007/s12975-017-0528-4. Epub 2017 Mar 1.
5
The High Cost of Stroke and Stroke Cytoprotection Research.中风及中风细胞保护研究的高昂成本
Transl Stroke Res. 2017 Aug;8(4):307-317. doi: 10.1007/s12975-016-0518-y. Epub 2016 Dec 30.
6
Regulatory T Cell Therapy for Ischemic Stroke: how far from Clinical Translation?缺血性中风的调节性T细胞疗法：距离临床转化还有多远？
Transl Stroke Res. 2016 Oct;7(5):415-9. doi: 10.1007/s12975-016-0476-4. Epub 2016 Jun 16.
7
Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection.急性缺血性中风患者的关键早期溶栓和血管内再灌注治疗：呼吁辅助神经保护。
Transl Stroke Res. 2015 Oct;6(5):345-54. doi: 10.1007/s12975-015-0419-5. Epub 2015 Aug 29.
本文引用的文献
1
Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China.中国急性缺血性卒中发病4.5小时内溶栓治疗的成本效益分析
PLoS One. 2014 Oct 20;9(10):e110525. doi: 10.1371/journal.pone.0110525. eCollection 2014.
2
Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial.经颅激光疗法治疗急性中风：神经治疗有效性和安全性试验3的结果，一项III期临床终点器械试验
Stroke. 2014 Nov;45(11):3187-93. doi: 10.1161/STROKEAHA.114.005795. Epub 2014 Oct 7.
3
NeuroThera Effectiveness and Safety Trial 3: how do we align corporate and scientific integrity to complete and report pharma-sponsored trials properly?神经治疗有效性与安全性试验3：我们如何使企业诚信与科学诚信保持一致，以妥善完成并报告制药公司赞助的试验？
Stroke. 2014 Nov;45(11):3175-7. doi: 10.1161/STROKEAHA.114.006750. Epub 2014 Oct 7.
4
Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence.急性缺血性卒中3小时内重组组织型纤溶酶原激活剂的成本效益：当前证据
Stroke. 2014 Oct;45(10):3032-9. doi: 10.1161/STROKEAHA.114.005852. Epub 2014 Sep 4.
5
Full steam ahead with remote ischemic conditioning for stroke.全力推进中风的远程缺血预处理治疗。
Transl Stroke Res. 2014 Oct;5(5):535-7. doi: 10.1007/s12975-014-0363-9. Epub 2014 Jul 24.
6
Remote ischemic postconditioning alleviates cerebral ischemic injury by attenuating endoplasmic reticulum stress-mediated apoptosis.远程缺血后适应通过减轻内质网应激介导的细胞凋亡来减轻脑缺血损伤。
Transl Stroke Res. 2014 Dec;5(6):692-700. doi: 10.1007/s12975-014-0359-5. Epub 2014 Jul 22.
7
Desmoteplase as a potential treatment for cerebral ischaemia.地西他滨作为一种潜在的治疗脑缺血的药物。
Expert Opin Investig Drugs. 2014 Jun;23(6):865-73. doi: 10.1517/13543784.2014.911285. Epub 2014 Apr 28.
8
Variation in behavioral deficits and patterns of recovery after stroke among different rat strains.不同大鼠品系中风后行为缺陷及恢复模式的差异。
Transl Stroke Res. 2014 Oct;5(5):569-76. doi: 10.1007/s12975-014-0337-y. Epub 2014 Apr 8.
9
Impaired limb reaction to displacement of center of gravity in rats with unilateral striatal ischemic injury.单侧纹状体缺血性损伤大鼠肢体对重心位移的反应受损。
Transl Stroke Res. 2014 Oct;5(5):562-8. doi: 10.1007/s12975-014-0339-9. Epub 2014 Apr 2.
10
Improving the translation of animal ischemic stroke studies to humans.提高动物缺血性中风研究向人体研究的转化。
Metab Brain Dis. 2015 Apr;30(2):461-7. doi: 10.1007/s11011-014-9499-2. Epub 2014 Feb 15.
Zotero 插件